Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online April 27, 2007
Diabetes Care 30:2107-2112, 2007
DOI: 10.2337/dc06-1441
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
dc06-1441v1
30/8/2107    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paterson, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paterson, A. D.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cardiovascular and Metabolic Risk
Original Article

The Effect of Intensive Diabetes Treatment on Resting Heart Rate in Type 1 Diabetes

The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study

Andrew D. Paterson, MD1, Brandy N. Rutledge, PHD2, Patricia A. Cleary, MS2, John M. Lachin, SCD2, Richard S. Crow, MD3 for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group*

1 Program in Genetics and Genomic Biology, The Hospital for Sick Children, and Departments of Public Health Sciences, Psychiatry and Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada
2 Biostatistics Center, The George Washington University, Rockville, Maryland
3 Minnesota ECG Coding Center, Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, Minnesota

Address correspondence and reprint requests to Dr. Andrew Paterson, Program in Genetics and Genomic Biology, The Hospital for Sick Children, TMDT Building East Tower, Room 15-707, 101 College St., Toronto, ON M5G 1L7, Canada. E-mail: andrew.paterson{at}utoronto.ca

OBJECTIVE—Cardiovascular disease is a major cause of morbidity and mortality in individuals with type 1 diabetes. Resting heart rate (RHR) is a risk factor for cardiovascular disease in the general population, and case-control studies have reported a higher RHR in individuals with type 1 diabetes. In individuals with type 1 diabetes, there is a positive correlation between A1C and RHR; however, no prospective studies have examined whether a causal relationship exists between A1C and RHR. We hypothesized that intensive diabetes treatment aimed to achieve normal A1C levels has an effect on RHR in individuals with type 1 diabetes.

RESEARCH DESIGN AND METHODS—A total of 1,441 individuals with type 1 diabetes who participated in the Diabetes Control and Complications Trial (DCCT) had their RHR measured biennially by an electrocardiogram during the DCCT and annually for 10 years during the Epidemiology of Diabetes Interventions and Complications (EDIC) follow-up study.

RESULTS—During the DCCT, intensive treatment was associated with lower mean RHR than conventional treatment, both in adolescents (69.0 vs. 72.0 bpm [95% CI 62.8–75.7 and 65.7–78.9, respectively], P = 0.013) and adults (66.8 vs. 68.2 [65.3–68.4 and 66.6–69.8, respectively], P = 0.0014). During follow-up in the EDIC, the difference in RHR between the treatment groups persisted for at least 10 years (P < 0.0001).

CONCLUSIONS—Compared with conventional therapy, intensive diabetes management is associated with lower RHR in type 1 diabetes. The lower RHR with intensive therapy may explain, in part, its effect in reducing cardiovascular disease, recently demonstrated in type 1 diabetes.

Abbreviations: DCCT, Diabetes Control and Complications Trial • ECG, electrocardiogram • EDIC, Epidemiology of Diabetes Interventions and Complications Study • RHR, resting heart rate • SBP: systolic blood pressure


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin. DiabetesHome page
M. J. Fowler
Microvascular and Macrovascular Complications of Diabetes
Clin. Diabetes, April 1, 2008; 26(2): 77 - 82.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.